Soiken Holdings (TSE:2385) Beneish M-Score: -3.42 (As of Jul. 06, 2026)


TSE:2385 Soiken Holdings Inc TSE:2385
56 GF Score
Price 円209.00
GF Value 円114.55
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Soiken Holdings Beneish M-Score?

Soiken Holdings TSE:2385 +1.46% 56 Beneish M-Score is -3.42 as of Jul. 06, 2026. GuruFocus rates TSE:2385 with a GF Score™ of 56/100 and a GF Value™ of 円114.55 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 825 Biotechnology companies, Soiken Holdings ranks better than 82.42% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -3.42 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Soiken Holdings's Beneish M-Score or its related term are showing as below:

TSE:2385' s Beneish M-Score Range Over the Past 10 Years
Min: -3.42   Med: -2.38   Max: -2.06
Current: -3.42

During the past 13 years, the highest Beneish M-Score of Soiken Holdings was -2.06. The lowest was -3.42. And the median was -2.38.


Soiken Holdings Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Soiken Holdings's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Soiken Holdings Beneish M-Score Chart

Soiken Holdings Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.37 -3.24 -2.56 -2.13 -3.42

Soiken Holdings Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -3.42 0.00 0.00

TSE:2385 vs VRTX, REGN, ALNY: Beneish M-Score Comparison

For the Biotechnology subindustry, Soiken Holdings's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Soiken Holdings Beneish M-Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Soiken Holdings's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Soiken Holdings's Beneish M-Score falls into.


TSE:2385
56GF Score
Soiken Holdings Inc TSE:2385
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Soiken Holdings Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Soiken Holdings for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.5553+0.528 * 0.968+0.404 * 1.3072+0.892 * 0.9399+0.115 * 0.8646
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1+4.679 * -0.112823-0.327 * 1.1331
=-3.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Jun25) TTM:Last Year (Jun24) TTM:
Total Receivables was 円224 Mil.
Revenue was 円4,849 Mil.
Gross Profit was 円2,410 Mil.
Total Current Assets was 円6,597 Mil.
Total Assets was 円6,813 Mil.
Property, Plant and Equipment(Net PPE) was 円10 Mil.
Depreciation, Depletion and Amortization(DDA) was 円18 Mil.
Selling, General, & Admin. Expense(SGA) was 円0 Mil.
Total Current Liabilities was 円756 Mil.
Long-Term Debt & Capital Lease Obligation was 円0 Mil.
Net Income was 円-211 Mil.
Gross Profit was 円0 Mil.
Cash Flow from Operations was 円558 Mil.
Total Receivables was 円429 Mil.
Revenue was 円5,158 Mil.
Gross Profit was 円2,482 Mil.
Total Current Assets was 円6,765 Mil.
Total Assets was 円6,946 Mil.
Property, Plant and Equipment(Net PPE) was 円20 Mil.
Depreciation, Depletion and Amortization(DDA) was 円27 Mil.
Selling, General, & Admin. Expense(SGA) was 円0 Mil.
Total Current Liabilities was 円680 Mil.
Long-Term Debt & Capital Lease Obligation was 円0 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(223.883 / 4848.534) / (428.934 / 5158.458)
=0.046175 / 0.083152
=0.5553

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(2482.372 / 5158.458) / (2410.475 / 4848.534)
=0.481224 / 0.497155
=0.968

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (6597.302 + 9.601) / 6812.899) / (1 - (6765.144 + 20.316) / 6946.134)
=0.030236 / 0.023131
=1.3072

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=4848.534 / 5158.458
=0.9399

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(26.802 / (26.802 + 20.316)) / (18.466 / (18.466 + 9.601))
=0.568827 / 0.657926
=0.8646

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(0 / 4848.534) / (0 / 5158.458)
=0 / 0
=1

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0 + 756.194) / 6812.899) / ((0 + 680.389) / 6946.134)
=0.110994 / 0.097952
=1.1331

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-210.696 - 0 - 557.955) / 6812.899
=-0.112823

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Soiken Holdings has a M-score of -3.42 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -3.42 mean?
Soiken Holdings (TSE:2385) has a Beneish M-Score of -3.42 as of Jul. 06, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Soiken Holdings and its competitors. According to the industry distribution chart, Soiken Holdings ranks #145 out of 825 companies in the Biotechnology industry, placing it in the top 17.6%.
Is Soiken Holdings' Beneish M-Score too high?
Soiken Holdings' current Beneish M-Score is -3.42. Based on the distribution chart, Soiken Holdings ranks #145 out of 825 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Soiken Holdings has a GF Score™ of 56/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Soiken Holdings' Beneish M-Score compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Soiken Holdings ranks #145 out of 825 companies for Beneish M-Score. This places Soiken Holdings in the top 18% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Biotechnology company?
A good Beneish M-Score depends on the Biotechnology industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Soiken Holdings and its competitors. Soiken Holdings's current Beneish M-Score is -3.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Soiken Holdings stock overvalued right now?
Based on GuruFocus' analysis, Soiken Holdings (TSE:2385) is currently considered Significantly Overvalued. The stock's GF Value™ is 円114.55, compared to a current price of 円209.00 — trading 82.5% above its estimated fair value. The current Beneish M-Score is -3.42. Soiken Holdings' overall GF Score™ is 56/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Soiken Holdings (TSE:2385), the current Beneish M-Score is -3.42 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Soiken Holdings (TSE:2385) Overvalued in 2026?

Based on GuruFocus' analysis, Soiken Holdings stock appears to be overvalued. The current stock price of 円209.00 is trading 82.5% above its estimated GF Value™ of 円114.55. GuruFocus considers Soiken Holdings to be Significantly Overvalued.

Key valuation signals for TSE:2385:

  • Beneish M-Score: -3.42
  • GF Value™: 円114.55 vs. price of 円209.00 (82.5% above fair value)
  • GF Score™: 56/100 with 3 warning signs

No single metric tells the full story. See the TSE:2385 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Soiken Holdings Business Description

Address 1-4-2 Shinsenri-Higashimachi, 13th Floor, Senri Life Science Center, Toyonaka, Osaka, JPN, 560-0082
Soiken Holdings Inc operates as a biotechnology company in Japan. It provides clinical testing for pharmaceutical and food manufacturers that develop drugs and health food products based on biomarkers. It is involved in the marketing research and post-marketing surveillance of health supplements.
56GF Score

Get the complete analysis for TSE:2385

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円209.00
Price
円114.55
GF Value